Determining the feasibility of linked claims and vaccination data for a Covid-vaccine pharmaco-epidemiological study in Germany – RiCO feasibility study protocol

Nina Timmesfeld, Peter Ihle, Robin Denz, Katharina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski, Hans H. Diebner, Ingo Meyer
doi: https://doi.org/10.1101/2024.03.04.24303714

Data Availability

The data used for the present study are not available for further use.

Back to top
Posted March 07, 2024.
Download PDF
Data/Code
Email
Determining the feasibility of linked claims and vaccination data for a Covid-vaccine pharmaco-epidemiological study in Germany – RiCO feasibility study protocol
Nina Timmesfeld, Peter Ihle, Robin Denz, Katharina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski, Hans H. Diebner, Ingo Meyer
medRxiv 2024.03.04.24303714; doi: https://doi.org/10.1101/2024.03.04.24303714
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area